Influence of Nociception Level Monitor (NOL) Guided Analgesic Delivery on the Perioperative Course, Quality of Recovery and Hospital Stay in Robot-assisted Colorectal Surgery
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Opioid Use, Unspecified
- Sponsor
- University of Southern Denmark
- Enrollment
- 60
- Locations
- 1
- Primary Endpoint
- Total intraoperative consumption of sufentanil Total intraoperative consumption of sufentanil
- Status
- Recruiting
- Last Updated
- last year
Overview
Brief Summary
Being relatively new, the NOL monitor may offer interesting observations in perioperative nociception levels and appropriate analgesic consumption in diverse surgeries, including robot-assisted surgery. These observations may supplement the current efforts towards further advantages in rapid restitution. Therefore, the investigators planned a trial where intra-operative analgesics were guided using an NOL monitor to study if intra-operative NOL guidance influences peri-operative analgesic consumption, postoperative length of stay and quality of recovery of patients subjected for robot-assisted surgery.
Detailed Description
During anesthesia for surgical procedures, anesthetic and muscle relaxant drugs can be meticulously administered using Bispectral Index (BIS) and neuromuscular monitors. However, analgesic drugs are still dispensed using poor surrogate parameters such as heart rate and blood pressure. This subjective dosing of analgesic drugs may invariably lead to inappropriate intra-operative consumption. This may result in tachycardia, hypertension, and postoperative pain due to e.g. insufficient analgesia, or hypotension, bradycardia, respiratory depression and Post-Operative Nausea and Vomiting (PONV) secondary to excessive analgesia. These effects may be detrimental to the patients especially those with multiple comorbidities with limited vital organ reserves such as patients classified to III or IV by the American Society of Anaesthesia classification (ASA) Similarly, immediate postoperative recovery may also get delayed due to pain, unstable hemodynamics, nausea and vomiting. In that context, there has long been search for a monitor which can guide meticulous administration of analgesics. Recently, a Nociception Level monitor (NOL) based on advanced software algorithms using multiple physiological parameters has been developed. It offers an objective score (NOL Index) which relates to the level of intra-operative pain. NOL technology has been validated and found superior to existing pain indicators in peer-reviewed publications. The NOL monitor may offer interesting observations in perioperative nociception levels and appropriate analgesic consumption in diverse surgeries, including robot-assisted surgery. These observations may supplement the current efforts towards further advantages in rapid restitution. Therefore, the investigators are planning a trial where intra-operative analgesics are guided using an NOL monitor.
Investigators
Eligibility Criteria
Inclusion Criteria
- •American Society of Anaesthesiologists score III-IV
- •Scheduled for elective major robot-assisted colorectal surgeries
Exclusion Criteria
- •Inability to give informed consent
- •planned spinal or epidural anaesthesia
- •all forms of regional anaesthesia, including wound infiltration
- •nonelective procedures
- •pregnancy or lactation
- •atrial fibrillation
Outcomes
Primary Outcomes
Total intraoperative consumption of sufentanil Total intraoperative consumption of sufentanil
Time Frame: From induction of anaesthesia up to transfer to recovery room, up to 6 hours
Amount of sufentanil in micrograms administered during the entire operative period i.e. from induction of anaesthesia up to transfer to the recovery room
Secondary Outcomes
- Change in myocardial function(Before anaesthesia induction and 24 hours after completion of surgery)
- Postoperative Nausea and Vomiting(From admission to recovery room, up to 24 hours)
- Eligible time to discharge as per RR discharge score(From admission to recovery room until discharge, up to 24 hours)